H
Hector Lantigua
Researcher at Columbia University
Publications - 21
Citations - 1146
Hector Lantigua is an academic researcher from Columbia University. The author has contributed to research in topics: Subarachnoid hemorrhage & Vasospasm. The author has an hindex of 15, co-authored 21 publications receiving 961 citations. Previous affiliations of Hector Lantigua include NewYork–Presbyterian Hospital & Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
Subarachnoid hemorrhage: who dies, and why?
Hector Lantigua,Santiago Ortega-Gutierrez,J. Michael Schmidt,Kiwon Lee,Neeraj Badjatia,Sachin Agarwal,Jan Claassen,E. Sander Connolly,Stephan A. Mayer +8 more
TL;DR: Strategies directed toward minimizing early brain injury and aneurysm rebleeding, along with prevention and treatment of medical complication, hold the best promise for further reducing mortality after SAH.
Journal ArticleDOI
Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes.
Jan Claassen,Adler J. Perotte,David J. Albers,Samantha Kleinberg,J. Michael Schmidt,Bin Tu,Neeraj Badjatia,Hector Lantigua,Lawrence J. Hirsch,Stephan A. Mayer,E. Sander Connolly,George Hripcsak +11 more
TL;DR: The systemic and cerebral physiologic effects of seizures after acute brain injury are poorly understood and the cause of secondary brain injury is poorly understood.
Journal ArticleDOI
Clinical Prediction Models for Aneurysmal Subarachnoid Hemorrhage: A Systematic Review
Blessing N.R. Jaja,Michael D. Cusimano,Nima Etminan,Daniel Hänggi,David Hasan,Don Ilodigwe,Hector Lantigua,Peter D. Le Roux,Benjamin Lo,Ada Louffat-Olivares,Stephan A. Mayer,Andrew J. Molyneux,Audrey Quinn,Tom A. Schweizer,Thomas Schenk,Julian Spears,Michael M. Todd,James C. Torner,Mervyn D.I. Vergouwen,George K.C. Wong,Jeff Singh,R. Loch Macdonald +21 more
TL;DR: While clinical prediction models for aSAH use a few simple predictors, there are substantial methodological problems with the models and none have had external validation, which precludes the use of existing models for clinical or research purposes.
Journal ArticleDOI
High-dose midazolam infusion for refractory status epilepticus
Andres Fernandez,Hector Lantigua,Christine Lesch,Belinda Shao,Brandon Foreman,J. Michael Schmidt,Lawrence J. Hirsch,Stephan A. Mayer,Jan Claassen +8 more
TL;DR: High-dose cIV-MDZ treatment of refractory status epilepticus can be performed safely, is associated with a lower seizure rate after cIV -MDZ discontinuation, and may be associated with lower mortality than traditional lower-dose protocols.
Journal ArticleDOI
Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study
Deborah Pugin,Brandon Foreman,Gian Marco De Marchis,Andres Fernandez,J. Michael Schmidt,Barry M. Czeisler,Stephan A. Mayer,Sachin Agarwal,Christine Lesch,Hector Lantigua,Jan Claassen +10 more
TL;DR: cIV-PTB effectively aborts SRSE and complications are infrequent; outcome in this highly refractory cohort of patients with devastating underlying etiologies remains poor.